HFSP Grant awardee Erin O’Shea elected Vice President of HHMI

Our congratulations go to Erin O’Shea of Harvard University.

The Howard Hughes Medical Institute (HHMI) has announced that Erin O’Shea was elected as the organization’s new Vice President and Chief Scientific Officer. Erin was a 2005 HFSP Grant awardee and later served on the HFSP Review Committee for Research Grants. Together with her HFSP co-investigators she was studying functional and dynamic aspects of information processing in yeast regulatory networks by high-throughput experiments. Her outstanding research and experience working with colleagues from around the world and across scientific borders make her the ideal candidate for this highly influential position.

Currently Erin is the Director of the Harvard Faculty of Arts and Sciences’ (FAS) Center for Systems Biology and the Paul C. Mangelsdorf Professor of Molecular and Cellular Biology and Chemistry and Chemical Biology at Harvard University.

In her new role, starting in January 2013, Erin O’Shea will be responsible for overseeing the HHMI scientific portfolio including the renowned Investigator Program which aims to support early career scientists. The full press release from HHMI is available here.